Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Toxicologic Pathology
This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schuh, J. C.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuh, J. C.L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Trials, Tribulations, and Trends in Tumor Modeling in Mice

Joann C.L. Schuh

Applied Veterinary Pathobiology, Bainbridge Island, Washington 98110-3663, USA, schuhj{at}bainbridge.net

Selection of mouse models of cancer is often based simply on availability of a mouse strain and a known compatible tumor. Frequently this results in use of tumor models long on history but short on homology and quality control. Other factors including genetics, sex, immunological status, method and site of tumor implantation, technical competence, biological activity of the tumor, protocol sequence and timing, and selection of endpoints interact to produce outcomes in tumor models. Common reliance on survival and tumor burden data in a single mouse model often skews expectations towards high remission and cure rates; a finding seldom duplicated in clinical trials. Inherent limitations of tumor models coupled with the advent of new therapeutic targets reinforce need for careful attention to design, conduct, and stringent selection of in vivo and ex vivo endpoints. Preclinical efficacy testing for anti-tumor therapies should progress through a series of models of increasing sophistication that includes incorporation of genetically engineered animals, and orthotopic and combination therapy models. Pharmacology and safety testing in tumor-bearing animals may also help to improve predictive value of these models for clinical efficacy. Trends in bioinformatics, genetic refinements, and specialized imaging techniques are helping to maintain mice as the most scientifically and economically powerful model of malignant neoplasms.

Key Words: Preclinical efficacy testing • tumor models • study design • xenograft • orthotopic tumors • genetically engineered mice • bioinformatics • bioimaging.

References

  • Abate-Shen, C., and Shen, M.M. (2002). Mouse models of prostate carcinogenesis. Trends Genet 18, S1—S5.[CrossRef][Medline] [Order article via Infotrieve]
  • Alvarez, E. (2002). B16 murine melanoma: historical perspective on the development of a solid tumor model. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • An, Z., Jiang, P., Wang, X., Moossa, A.R., and Hoffman, R.M. (1999). Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection. Clin Exp Metastasis 17, 265—70.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Anderson, R.N. (2002). Deaths: leading causes for 2000. National Vital Statistics Report 50, 12—4.
  • Arias E., and Smith, B.L. (2003). Deaths: preliminary data for 2001. National Vital Statistics Report 51, 1—16.
  • Artandi, S.E. (2002). Telomore shortening and cell fates in mouse models of neoplasia. Trends Mol Med 8, 44—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Atassi, G., Dumont, P., Kabbe, H.J., and Yoder, O. (1988). A new antitumour agent, batracylin, selected by a preclinical solid tumour model. Drugs Exp Clin Res 14, 571—4.[Web of Science][Medline] [Order article via Infotrieve]
  • Averbook, B., Schuh, J.C.L., Papay, R., and Maliszewski, C. (2002). Antitumor effects of flt3 ligand in transplanted murine tumor models. J Immunother 25, 27—35.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Balmain, A. (2002). Cancer as a complex genetic trait: tumor susceptibility in humans and mouse models. Cell 108, 145—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bankert, R.B., Egilmez, N.K., and Hess, S.D. (2001). Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies. Trends Immunol 22, 386—93.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bankert, R.B., Hess, S.D., and Egilmez, N.K. (2002). SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions. Front Biosci 7, 44—62.
  • Bardeesy, N., Sharpless, N.E., DePinho, R.A., and Merlino, G. (2001). The genetics of pancreatic adenocarcinoma: a roadmap for a mouse model. Semin Cancer Biol 11, 201—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Begemann, M., Fuller, G.N., and Holland, E.C. (2002). Genetic modeling of glioma formation in mice. Brain Pathol 12, 117—32.[Web of Science][Medline] [Order article via Infotrieve]
  • Beltinger, C., and Debatin, K.-M. (2001). Murine models for experimental therapy of pediatric solid tumors with poor prognosis. Int J Cancer 92, 313—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bernardi, R., Grisendi, S., and Pandolfi, P.P. (2002). Modelling haematopoietic malignancies in the mouse and therapeutical implications. Oncogene 21, 3445—58.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Berr, S.S., Roche, J.K., El-Rifai, W., Smith Jr., M.F., and Powell, S.M. (2003). Magnetic resonance imaging of gastric cancer in Tff1 knock-out mice. Magn Reson Med 49, 1033—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bloomston, M., Zervos, E.E., and Rosemurgy II, A.S. (2002). Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 9, 668—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bogden, A.E., Esber, H.J., Taylor, D.J., and Gray, J.H. (1974). Comparative study on the effects of surgery, chemotherapy, and immunotherapy, alone and in combination, on metastases of the 13762 mammary adenocarcinoma. Cancer Res 34, 1627—31.[Abstract/Free Full Text]
  • Boivin, G.P., Washington, K., Yang, K., Ward, J.M., Pretlow, T.P., Russell, R., Besselsen, D.G., Godfrey, V.L., Doetschman, T., Dove, W.F., Pitot, H.C., Halberg, R.B., Itzkowitz, S.H., Groden, J., and Coffey, R.J. (2003). Pathology of mouse models of intestinal cancer: consensus report and recommendations. Gastroenterology 124, 762—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Bonfil, R.D., Russo, D.M., Binda, M.M., Delgado, F.M., and Vincenti, M. (2002). Higher antitumor activity of vinflunine than vinorelbine against an orthotopic murine model of transitional cell carcinoma of the bladder. Urol Oncol 7, 159—66.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Boone, C.W., Steele, V.E., and Kelloff, G.J. (1992). Screening for chemopreventive (anticarcinogenic) compounds in rodents. Mutat Res 267, 251—5.[Web of Science][Medline] [Order article via Infotrieve]
  • Boyd, D.D., Kim, S.J., Wang, H., Jones, T.R., and Gallick, G.E. (2003). A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis. Am J Pathol 162, 619.[Abstract/Free Full Text]
  • Burger, M.M. (2000). UICC study group on basic and clinical cancer research: animal models for the natural history of cancer. Int J Cancer 85, 303—5.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Burgos, J.S., Rosol, M., Moats, R.A., Khankaldyyan, V., Kohn, D.B., Nelson Jr., M.D., and Laug, W.E. (2003). Time course of bioluminescent signal in orthotopic and heterotopic brain tumors in nude mice. BioTechniques 34, 1184—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Cardiff, R.D. (2001). Validity of mouse mammary tumour models for human breast cancer: comparative pathology. Microsc Res Tech 52, 224—30.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Carson III, W.E., and Walker, M.J. (2002). Animal models of melanoma. Tumor Models in Cancer Research, Teicher B. A Humana Press, Totowa, NJ.
  • Casas, A., Fukuda, H., Meiss, R., and Batlle, A.M. (1999). Topical and intratumoral photodynamic therapy with 5-aminolevulinic acid in a subcutaneous murine mammary adenocarcinoma. Cancer Lett 141, 29—38.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Castillo, R., Diaz, J.W., Veloso, A., and Gavilondo, J. (1982). Leukemoid reaction induced by different transplantable tumors in three inbred mouse strains. Neoplasma 29, 73—9.[Web of Science][Medline] [Order article via Infotrieve]
  • Chakrabarty, A., Hillman, G.G., Maughan, R.L., Visscher, D.W., Ali, E., Pontes, J.E., and Haas, G.P. (1994). Influence of tumor site on the therapy of murine kidney cancer. Anticancer Res 14, 373—8.[Web of Science][Medline] [Order article via Infotrieve]
  • Chen, J.J.W., Peck, K., Hong, T.-M., Yang, S.-C., Sher, Y.-P., Shih, J.-Y., Wu, R., Cheng, J.-L., Roffler, S.R., Wu, C.-W., and Yang, P.-C. (2001). Global analysis of gene expression in invasion by a lung cancer model. Cancer Res 61, 5223—30.[Abstract/Free Full Text]
  • Clarke, R. (2002). Human breast-cancer xenografts as models of the human disease. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Corbett, T.H., Griswold Jr, D.P., Wolpert, M.K., Venditti, J.M., and Schabel Jr., F.M. (1979). Design and evaluation of combination chemotherapy trials in experimental animal tumor systems. Cancer Treat Rep 63, 799—801.[Web of Science][Medline] [Order article via Infotrieve]
  • Corbett, T.H., Panchapor, C., Polin, L., Lowichik, N., Pugh, S., White, K., Kushner, J. Meyer, J., Czarnecki, J., Chinnukroh, S., Edelstein, M., LoRusso, P., Heilbrun, L., Horwitz, J.P., Grieshaber, C., Perni, R., Wentland, M., Coughlin, S., Elenbaas, S., Philion, R., and Rake, J. (1999). Preclinical efficacy of thioxanthone SR271425 against transplanted solid tumors of mouse and human origin. Invest New Drugs 17, 17—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Corbett, T.H., Polin, L., Roberts, B.J., Lawson, A.J., Leopold, III W.R., White, K., Kushner, J., Paluch, J., Hazeldine, S., Moore, R., Rake, J., and Horwitz, J.P. (2002). Transplantable syngeneic rodent tumors: solid tumors in mice. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Couse, J.F., Davis, V.L., Hanson, R.B., Jefferson, W.N., McLachlan, J.A., Bullock, B.C., Newbold, R.R., and Korach, K.S. (1997). Accelerated onset of uterine tumors in transgenic mice with aberrant expression of the estrogen receptor after neonatal exposure to diethylstilbestrol. Mol Carcinog 19, 236—42.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Culp, L.A., Holleran, J.L., and Miller, C.J. (2001). Tracking prostate carcinoma micrometastasis to multiple organs using histochemical marker genes and novel cell systems. Histol Histopathol 16, 945—53.[Web of Science][Medline] [Order article via Infotrieve]
  • Dellian, M., Witwer, B.P., Salehi, H.A., Yuan F., and Jain, R.K. (1996). Effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am J Pathol 149, 59—71.[Abstract]
  • Dewhirst, M.W., Thrall, D., and MacEwen, E.G. (2002). Spontaneous pet animal cancers. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Diament, M.J., Garcia, C., Stillitani, I., Saavedra, V.M., Manzur, T., Vauthay, L., and Klein, S. (1998). Spontaneous murine lung adenocarcinoma (P07): a new experimental model to study paraneoplastic syndromes of lung cancer. Int J Mol Med 2, 45—50.[Web of Science][Medline] [Order article via Infotrieve]
  • Drexler, H.G., Dirks, W.G., Matsuo, Y., and MacLeod, R.A. (2003). False leukemia-lymphoma cell lines: an update on over 500 cell lines. Leukemia 17, 416—26.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Dvorak, H.F., Harvey, V.S., Estrella, P., Brown, L.F., McDonagh, J., and Dvorak, A.M. (1987). Fibrin containing gels induce angiogenesis. Implications for tumor stroma generation and wound healing. Lab Invest 57, 673—86.[Web of Science][Medline] [Order article via Infotrieve]
  • Dykes, D.J., and Waud, W.R. (2002). Murine L1210 and P388 Leukemias. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Eccles, S.A. (2002). Models for evaluation of targeted therapies of metastatic disease. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Edinger, M., Sweeney, T.J., Tucker, A.A., Olomu, A.B., Negrin, R.S., and Contag, C.H. (1999). Noninvasive assessment of tumor cell proliferation in animal models. Neoplasia 1, 303—10.[CrossRef][Medline] [Order article via Infotrieve]
  • Eto, M., Harada, M., Tamada, K., Tokuda, N., Koikawa, Y., Nakamura, M., Nomoto, K., and Naito, S. (2000). Antitumor activity of interleukin-12 against murine bladder cancer. J Urol 163, 1549—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Fausto, N. (1999). Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 19, 243—52.[Web of Science][Medline] [Order article via Infotrieve]
  • Feitelson, M.A., and Larkin, J.D. (2001). New animal models of hepatitis B and C. ILAR J 42, 127—38.[Medline] [Order article via Infotrieve]
  • Fogh, J., Fogh, J.M., and Orfeo, T. (1977). One hundred and twenty-seven cultured human tumor cell lines producing tumors in nude mice. J Natl Cancer Inst 59, 221—6.[Web of Science][Medline] [Order article via Infotrieve]
  • Fu, X., Guadagni, F., and Hoffman, R.M. (1992). A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci USA 89, 5645—9.[Abstract/Free Full Text]
  • Furukawa, T., Kubota, T., Watanabe, M., Kitajima, M., and Hoffman, R.M. (1993a). A novel "patient-like" treatment model of human pancreatic cancer constructed using orthotopic transplantation of histologically intact human tumor tissue in nude mice. Cancer Res 53, 3070—2.[Abstract/Free Full Text]
  • Furukawa, T., Kubota, T., Watanabe, M., Kuo, T.H., Kitajima, M., and Hoffman, R.M. (1993b). Differential chemosensitivity of local and metastatic human gastric cancer after orthotopic transplantation of histologically intact tumor tissue in nude mice. Int J Cancer 54, 397—401.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Gaudet, F., Hodgson, J.G., Eden, A., Jackson-Grusby, L., Dausman, J., Gray, J.W., Leonhardt, H., and Jaenisch, R. (2003). Induction of tumors in mice by genomic hypomethylation. Science 300, 489.[Abstract/Free Full Text]
  • Gershwin, M.E., Ikeda, R.M., Kawakami, T.G., and Owens, R.B. (1977). Immunobiology of heterotransplanted human tumors in nude mice. J Natl Cancer Inst 58, 1455—60.[Web of Science][Medline] [Order article via Infotrieve]
  • Giard, D.J., Aaronson, S.A., Todaro, G.J., Arnstein, P., Kersey, J.H., Dosik, H., andParks, W.P. (1973). In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst 51, 1417—23.[Web of Science][Medline] [Order article via Infotrieve]
  • Giovanella, B. (2002). Xenotransplantation of human cell cultures in nude mice. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Giraldi, T., Zorzet, S., Perissin, L., and Rapozzi, V. (2000). Stress and chemotherapy: combined effects on tumor progression and immunity in animal models. Ann NY Acad Sci 917, 549—59.[Web of Science][Medline] [Order article via Infotrieve]
  • Goodman, J.I., and Watson, R.E. (2002). Altered DNA methylation: a secondary mechanism involved in carcinogenesis. Annu Rev Pharmacol Toxicol 42, 501—25.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Goytisolo, F.A., and Blasco, M.A. (2002). Many ways to telomere dysfunction: in vivo studies using mouse models. Oncogene 21, 584—91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Granger, M.P., Wright, W.E., and Shay, J.W. (2002). Telomerase in cancer and aging. Crit Rev Oncol Hematol 41, 29—40.[Web of Science][Medline] [Order article via Infotrieve]
  • Gunduz, N., Fisher, B., and Saffer, E.A. (1979). Effect of surgical removal on the growth and kinetics of residual tumor. Cancer Res 39, 3861—5.[Abstract/Free Full Text]
  • Gutmann, D.H., Baker, S.J., Giovannini, M., Garbow, J., and Weiss, W. (2003). Mouse models of human cancer consortium symposium on nervous system tumors. Cancer Res 63, 3001—4.[Abstract/Free Full Text]
  • Hann, B., and Balmain, A. (2001). Building `validated' mouse models of human cancer. Curr Opin Cell Biol 13, 778—84.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Harrison, S. (2002). Perspective on the history of tumor models. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Hay, R.J. (1991). Operator-induced contamination in cell culture systems. Dev Biol Stand 75, 193—204.[Medline] [Order article via Infotrieve]
  • Herber, R., Liem, A., Pitot, H., and Lambert, P.F. (1996). Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene. J Virol 70, 1873—81.[Abstract]
  • Herzig, M., and Christofori, G. (2002). Recent advances in cancer research: mouse models of tumorigenesis. Biochim Biophys Acta 1602, 97—113.[Medline] [Order article via Infotrieve]
  • Heyer, J., Yang, K., Lipkin, M., Edelmann, W., and Kucherlapati, R. (1999). Mouse models for colorectal cancer. Oncogene 18, 5325—33.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hillman, G.G. (2002). Experimental animal models for renal cell carcinoma. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Hoffman, R.M. (1999). Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic. Invest New Drugs 174, 343—59.
  • Hoffman, R.M. (2002). Green fluorescent protein imaging of tumour growth, metastasis, and angiogenesis in mouse models. Oncology 3, 546—56.[Medline] [Order article via Infotrieve]
  • Holland, E.C. (2001). Brain tumor animal models: importance and progress. Curr Opin Oncol13, 143—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Hoon, D.S., Fujimoto, A., Shu, S., and Taback, B. (2002). Assessment of genetic heterogeneity in tumors using laser capture microdissection. MethEnzymol 356, 302—9.
  • Horig, H., Wainstein, A., Long, L., Kahn, D., Soni, S., Marcus, A., Edelmann, Kucherlapati, W.R., and Kaufman, H.L. (2001). A new mouse model for evaluating the immunotherapy of human colorectal cancer. Cancer Res 61, 8520.[Abstract/Free Full Text]
  • Hotz, H.G., Hines, O.J., Foitzik, T., and Reber, H.A. (2000). Animal models of exocrine pancreatic cancer. Int J Colorectal Dis 15, 136—43.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Houghton, P.J., Adamson, P.C., Blaney, S., Fine, H.A., Gorlick, R., Haber, M., Helman, L., Hirschfeld, S., Hollingshead, M.G., Israel, M.A., Lock, R.B., Maris, J.M., Merlino, G., Patterson, W., Reynolds, C.P., Shannon, K., Yu, A., Yu, J., and Smith, M.A. (2002). Testing of new agents in childhood cancer preclinical models: meeting summary. Clin Cancer Res 8, 3646—57.[Abstract/Free Full Text]
  • Hursting, S.D. (1997). Experimental models of gene-environment interaction for cancer chemoprevention studies. Curr Opin Oncol 9, 487—91.[Medline] [Order article via Infotrieve]
  • Huseby, R.A. (1969). Utility and failure of models in oncology. Fed Proc 28, 211—5.[Web of Science][Medline] [Order article via Infotrieve]
  • Hutchinson, J.N., and Muller, W.J. (2000). Transgenic mouse models of human breast cancer. Oncogene 19, 6130—7.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jackson-Grusby, L. (2002). Modeling cancer in mice. Oncogene 21, 5504—14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Jain, R.K., Munn, J.J., and Fukumura, D. (2002). Transparent window models and intravital microscopy: imagine gene expression, physiological function, and drug delivery in tumors. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Jonkers, J., and Berns, A. (2002). Conditional mouse models of sporadic cancer. Nat Rev Cancer 2, 251—65.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Justice, M.J., Noveroske, J.K., Weber, J.S., Zheng, B., and Bradley, A. (1999). Mouse ENU mutagenesis. Hum Mol Genet 8, 1955.
  • Kennel, S.J., Lankford, T., Davern, S., Foote, L., Taniguchi, K., Ohizumi, I., Tsutsumi, Y., Nakagawa, S., Mayumi, T., and Mirzadeh, S. (2002). Therapy of rat tracheal carcinoma IC-12 in SCID mice: vascular targeting with [213Bi]-MAb TES-23. Eur J Cancer 38, 1278—87.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kerbel, R.S. (1999). What is the optimal rodent model for anti-tumor drug testing? Cancer Metastasis Rev 17, 301—4.[CrossRef][Web of Science]
  • Keshavarzi, A., Vaezy, S., Noble, M.L., Chi, E.Y., Walker, C., Martin, R.W., and Fujimoto, V.Y. (2002). Treatment of uterine leiomyosarcoma in a xenograft nude mouse model using high-intensity focused ultrasound: a potential treatment modality for recurrent pelvic disease. Gynecol Oncol 86, 344—50.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Killion, J.J., Radinsky, R., and Fidler, I.J. (1999). Orthotopic models are necessary to predict therapy of transplantable tumors in mice. Cancer Metastasis Rev 17, 284.
  • Klatt, P., and Serrano, M. (2003). Engineering cancer resistance in mice. Carcinogenesis 24, 817.[Abstract/Free Full Text]
  • Klausner, R.D. (1999). Studying cancer in the mouse. Oncogene 18, 5249—52.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Knapp, D.W., and Waters, D.J. (1997). Naturally occurring cancer in pet dogs: important models for developing improved cancer therapy for humans. Mol Med Today 3, 8—11.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kobaek-Larsen, M., Thorup, I., Diederichsen, A., Fenger, C., and Hoitinga, M.R. (2000). Review of colorectal cancer and its metastases in rodent models: comparative aspects with those in humans. Comp Med 50, 16—26.[Web of Science][Medline] [Order article via Infotrieve]
  • Koike, K. (2002). Hepatocarcinogenesis in hepatitis viral infection: lessons from transgenic mouse studies. J Gastroenterol 37, 55—64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kristjansen, P.E.G. (2002). Tissue-isolated tumors in mice: ex vivo perfusion of human tumor xenografts. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Kruger, A., Schirrmacher, V., and Khokha, R. (1999). The bacterial lacZ gene: an important tool for metastasis research and evaluation of new cancer therapies. Cancer Metastasis Rev 17, 285—94.[Web of Science]
  • Kunstfeld, R., Wickenhauser, G., Michaelis, U., Teifel, M., Umek, W., Naujoks, K., Wolff, K., and Petzelbauer, P. (2003). Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model. J Invest Dermatol 120, 476—82.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Kuo, T.-H., Kubota, T., Watanabe, M., Furukawa, T., Kase, S., Tanino, H., Saikawa, Y., Ishibiki, K., Kitajima, M., and Hoffman, R.M. (1993). Sitespecific chemosensitivity of human small-cell lung carcinoma growing orthotopically compared to subcutaneously in SCID mice: the importance of orthotopic models to obtain relevant drug evaluation data. Anticancer Res 13, 627—30.[Web of Science][Medline] [Order article via Infotrieve]
  • Lapidot, T., Fajerman, Y., and Kollet, O. (1997). Immune-deficient SCID and NOD/SCID mice models as functional assays for studying normal and malignant human hematopoiesis. J Mol Med 75, 664—73.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Laster Jr., W.R., Schabel Jr, F.M., Skipper, H.E., Wilcox, W.S., and Thomson, J.R. (1961). Experimental evaluation of potential anticancer agents IV. host weight loss as it relates to false positives in drug evaluation. Cancer Res 21, 895—906.[Abstract/Free Full Text]
  • Li, C.Y., Shan, S., Huang, Q., Braun, R.D., Lanzen, J., Hu, K., Lin, P., and Dewhirst, M.W. (2000). Initial stages of tumor cell-induced angiogenesis: evaluation via skin window chambers in rodent models. J Natl Cancer Inst 92, 143—7.[Abstract/Free Full Text]
  • Liebelt, R.A., Gehring, G., Delmonte, L., Schuster, G., and Liebelt, A.G. (1974). Paraneoplastic syndromes in experimental animal model systems. Ann NY Acad Sci 230, 547—64.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Lin, J., Sahakian, D.C., de Morais, S.M., Xu, J.J., Polzer, R.J., and Winter, S.M. (2003). The role of absorption, distribution, metabolism, excretion and toxicity in drug discovery. Curr Top Med Chem 3, 1125—4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Liu, J., and Johnston, M.R. (2002). Animal models for studying lung cancer and evaluating novel intervention strategies. Surg Oncol 11, 217—27.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Maierhofer, C., Gangnus, R., Diebold, J., and Speicher, M.R. (2003). Multicolor deconvolution microscopy of thick biological specimens. Am J Pathol 162, 373.[Abstract/Free Full Text]
  • Malkinson, A.M. (2001). Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung. Lung Cancer 32, 265—79.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Manivasager, V., Heng, P.W., Hao, J., Zheng, W., Soo, K.C., and Olivo, M. (2002). Macro-microscopic fluorescence imaging of human NPC xenografts in a murine model using topical vs intravenous administration of 5-aminolevulinic acid. Int J Oncol 21, 1003—7.[Web of Science][Medline] [Order article via Infotrieve]
  • Manzotti, C., Audisio, R.A., and Pratesi, G. (1993). Importance of orthotopic implantation for human tumors as model systems: relevance to metastasis and invasion. Clin Exp Metastasis 11, 5—14.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • McClatchey A.I. (1999). Modeling metastasis in the mouse. Oncogene 18, 5334—9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Menon, K., and Teicher, B.A. (2002). Metastasis models: lungs, spleen/liver, bone, and brain. Tumor Models in Cancer Research, Teicher B. A. Humana Press, Totowa, NJ.
  • Meuwissen, R., Jonkers J., and Berns, A. (2001). Mouse models for sporadic cancer. Exp Cell Res 264, 100—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mickisch, G.H., Merlino, G.T., Galski, H., Gottesman, M.M., and Pastan, I. (1991). Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance. Proc Natl Acad Sci USA 88, 547—51.[Abstract/Free Full Text]
  • Monsky, W.L., Carreira, C.M., Tsuzuki, Y., Gohongi, T., Fukumura, D., and Jain, R.K. (2002). Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors. Clin Cancer Res 8, 1008—13.[Abstract/Free Full Text]
  • Moore, K.J., and Nagle, D.L. (2000). Complex trait analysis in the mouse: the strengths, the limitations and the promise yet to come. Annu Rev Genet 34, 653—86.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Moseley, G.W., Elliott, J., Wright, M.D., Partridge, L.J., and Monk, P.N. (2003). Interspecies contamination of the KM3 cell line: implications for CD63 function in melanoma metastasis. Int J Cancer 105, 613—6.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Mukherjee, P., El-Abbadi, M.M., Kasperzyk, J.L., Ranes, M.K., and Seyfried, T.N. (2002). Dietary restriction reduced angiogenesis and growth in an orthotopic mouse brain tumour model. Br J Cancer 86, 1615—21.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Myers, J.N., Holsinger, F.C., Jasser, S.A., Bekele, B.N., and Fidler, I.J. (2002). An orthotopic nude mouse model of oral tongue squamous cell carcinoma. Clin Cancer Res 8, 293—8.[Abstract/Free Full Text]
  • Naf, D., Krupke, D.M., Sundberg, J.P., Eppig, J.T., and Bult, C.J. (2002). The mouse tumor biology database: a public resource for cancer genetics and pathology of the mouse. Cancer Res 62, 1235.[Abstract/Free Full Text]
  • Naito, S., Giavazzi, R., Walker, S.M., Itoh, K., Mayo, J., and Fidler, I.J. (1987a). Growth and metastatic behavior of human tumor cells implanted into nude and beige nude mice. Clin Exp Metastasis 5, 135—46.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Naito, S., von Eschenback, A.C., and Fidler, I.J. (1987b). Different growth pattern and biologic behavior of human renal cell carcinoma implanted into different organs of nude mice. J Natl Cancer Inst 78, 377—85.[Web of Science][Medline] [Order article via Infotrieve]
  • Navone, N.M., Logothetis, C.J., von Eschenbach, A.C., and Troncoso, P. (1999). Model systems of prostate cancer: uses and limitations. Cancer Metastasis Rev 17, 361—71.[CrossRef][Web of Science]
  • Nelson, A.L., Algon, S.A., Munasinghe, J., Graves, O., Goumnerova, L., Burstein, D., Pomeroy, S.L., and Kim, J.Y. (2003). Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors. J Neurooncol 62, 259—67.[CrossRef][Medline] [Order article via Infotrieve]
  • Nicklas, W., Kraft, V., and Meyer, B. (1993). Contamination of transplantable tumors, cell lines, and monoclonal antibodies with rodent viruses. Lab Anim Sci 43, 296—300.[Web of Science][Medline] [Order article via Infotrieve]
  • Nyska, A., Dayan, A., and Maronpot, R.R. (2002). New tools in therapeutic research—prostatic cancer and models. Toxicol Pathol 30, 283—7.[Free Full Text]
  • Opitz, O.G., Harada, H., Suliman, Y., Rhoades, B., Sharpless, N.E., Kent, R., Kopelovich, L., Nakagawa, H., and Rustgi, A.K. (2002). A mouse model of human oral-esophageal cancer. J Clin Invest 110, 761.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Orsulic, S., Li, Y., Soslow, R.A., Vitale-Cross, L.A., Gutkind, J.S., and Varmus, H.E. (2002). Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 1, 53—62.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Paddock, S.W. (1999). Confocal laser scanning microscopy. BioTechniques 27, 992—1004.[Web of Science][Medline] [Order article via Infotrieve]
  • Pettaway, C.A., Pathak, S., Greene, G., Ramirez, E., Wilson, M.R., Killion, J.J., and Fidler, I.J. (1996). Selection of highly metastatic variants of different human prostatic carcinomas using orthotopic inplantation in nude mice. Clin Cancer Res 2, 1627—36.[Abstract]
  • Pitot, H.C. (2001). Animal models of neoplastic development. Develop Biol 106, 53—7.[CrossRef]
  • Rahman, N.A., and Huhtaniemi, I.T. (2001). Ovarian tumorigenesis in mice transgenic for murine inhibin alpha subunit promoter-driven Simian Virus 40 T-antigen ontogeny, functional characteristics, and endocrine effects. Biol Reprod 64, 1122—30.[Abstract/Free Full Text]
  • Rahman, N.A., Kananen Rilianawati, K., Paukku, T., Mikola, M., Markkula, M., Hamalainen, T., and Huhtaniemi, I.T. (1998). Transgenic mouse models for gonadal tumorigenesis. Mol Cell Endocrinol 145, 167—74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Ray, P., Wu, A.M., and Gambhir, S.S. (2003). Optical bioluminescence and positron emission tomography imaging of a novel fusion reporter gene in tumor xenografts of living mice. Cancer Res 63, 1160—5.[Abstract/Free Full Text]
  • Reilly, K.M., and Jacks, T. (2001). Genetically engineered mouse models of astrocytoma: GEMs in the rough? Semin Cancer Biol 11, 177—91.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Resor, L., Bowen, T.J., and Wynshaw-Boris, A. (2001). Unraveling human cancer in the mouse: recent refinements to modeling and analysis. Hum Mol Genet 10, 669—75.[Abstract/Free Full Text]
  • Rew, D.A. (2000a). Modelling in tumour biology part I: modelling concepts and structures. Eur J Surg Oncol 26, 78—94.
  • Rew, D.A. (2000b). Modelling in tumour biology part II: modelling cancer therapy. Eur J Surg Oncol 26, 181—8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Rideout III, W.M., Wakayama, T., Wutz, A., Eggan, K., Jackson-Grusby, L., Dausman, J., Yanagimachi, R., and Jaenisch, R. (2000). Generation of mice from wild-type and targeted ES cells by nuclear cloning. Nat Genet 24, 109—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Righi, L., Deaglio, S., Pecchioni, C., Gregorini, A., Horenstein, A.L., Bussolati, G., Sapino, A., and Malavasi, F. (2003). Role of CD31/platelet endothelial cell adhesion molecule-1 expression in in vitro and in vivo growth and differentiation of human breast cancer cells. Am J Pathol 162, 1163.[Abstract/Free Full Text]
  • Rosenberg, E., Holmes, M., Tenenholz, T., Khalil, A.E.R., and Valerie, K. (2003). Preservation of fluorescent protein activity in tumor tissue. BioTechniques 34, 476—80.[Web of Science][Medline] [Order article via Infotrieve]
  • Rosenberg, M.P., and Bortner, D. (1999). Why transgenic and knockout animal models should be used (for drug efficacy studies in cancer). Cancer Metastasis Rev 17, 295—9.[Web of Science]
  • Rosner, A., Miyoshi, K., Landesman-Bollag, E., Xu, X., Seldin, D.C., Moser, A.R., MacLeod, C.L., Shyamala, G., Gillgrass, A.E., and Cardiff, R.D. (2002). Pathway pathology: histological differences between ErbB/Ras and wnt pathway transgenic mammary tumors. Am J Pathol 161, 1087.[Abstract/Free Full Text]
  • Royal, R., Lange, P.H., and Vessella, R. (1996). Preclinical models of prostate cancer. Semin Oncol 23, 35—40.[Web of Science][Medline] [Order article via Infotrieve]
  • Ruggero, D., Grisendi, S., Piazza, F., Rego, E., Mari, F., Rao, P.H., Cordon-Cardo, C., and Pandolfi, P.P. (2003). Dyskeratosis congenita and cancer in mice deficient in ribosomal RNA modification. Science 299, 259.[Abstract/Free Full Text]
  • Sadar, M.D., Akopian, V.A., and Beraldi, E. (2002). Characterization of a new in vivo hollow fiber model for the study of progression of prostate cancer to androgen independence. Mol Cancer Ther 1, 629—37.[Abstract/Free Full Text]
  • Schipper, H., Goh, C.R., and Wang, T.L. (1995). Shifting the cancer paradigm: must we kill to cure? J Clin Oncol 801—7.
  • Schwartz, J., and Gu, X. (2002). Hamster oral cancer model. Tumor Models in Cancer Research, Teicher B. A., Humana Press, Totowa, NJ.
  • Seki, N., Hayakawa, Y., Brooks, A.D., Wine, J., Wiltrout, R.H., Yagita, H., Tanner, J.E., Smyth M.J., and Sayers, T.J. (2003). Tumor necrosis factor-related apoptosis-inducing ligant-mediated apoptosis is an important endogenous mechanism for resistance to liver metastases in murine renal cancer. Cancer Res 63, 207—13.[Abstract/Free Full Text]
  • Sharma, P., and Schreiber-Agus, N. (1999). Mouse models of prostate cancer. Oncogene 18, 5349—55.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Siemann, D.W. (1987). Satisfactory and unsatisfactory tumor models factors influencing the selection of a tumor model for experimental evaluation. Rodent Tumor Models in Experimental Cancer Therapy, Kallman, R. F., Pergamon Books, Inc, Elmsford, NY.
  • Skipper, H.E. (1968). Biochemical, biological, pharmacologic, toxicologic, kinetic, and clinical (subhuman and human) relationships. Cancer 21, 600— 10.[Medline] [Order article via Infotrieve]
  • Skipper, H.E. (1990). Tumor differences, drug differences, treatment design differences, and effects on therapeutic outcome (degree and duration of therapeutic response). Prog Clin Biol Res 354, 81—98.
  • Spitsbergen, J.M., and Kent, M.L. (2003). The state of the art of the zebrafish model for toxicology and toxicologic pathology research—advantages and current limitations. Toxicol Pathol 31, 62—87.[Abstract/Free Full Text]
  • Standop, J., Schneider, M.B., Ulrich, A., and Pour, P.M. (2001). Experimental animal models in pancreatic carcinogenesis: lessons for human pancreatic cancer. Dig Dis 19, 24—31.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Steel, G.G. (1987). How well do xenografts maintain the therapeutic response characteristics of the source tumor in the donor patient? Rodent Tumor Models in Experimental Cancer Therapy, Kallman, R. F., Pergamon Books, Inc, Elmsford, NY.
  • Strandberg, J.D. (2000). Comparative pathology of benign prostatic hyperplasia. Prostatic Diseases, Lepor, H. WB Saunders Co., Philadelphia, PA.
  • Suttie, A., Nyska, A., Haseman, J.K., Moser, G.J., Hackett, T.R., and Goldsworthy, T.L. (2003). A grading scheme for the assessment of proliferative lesions of the mouse prostate in the TRAMP model. Toxicol Pathol 31, 31—38.[Abstract/Free Full Text]
  • Tanaka, R., Okada, M., Kajimura, N., Otsubo, K., Gyotoku, M., Nagasaki, K., Ekimoto, H., and Yamaguchi, K. (1996). Triple paraneoplastic syndrome of hypercalcemia, leukocytosis and cachexia in two human tumor xenografts in nude mice. Jpn J Clin Oncol 26, 88—94.[Abstract/Free Full Text]
  • Teicher, B.A. (1997). Models for minimal residual tumor. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval. Teicher, B. A Humana Press Inc., Totowa, NJ.
  • Teicher, B.A. (2002). In vivo tumor response end points. Tumor Models in Cancer Research. Teicher, B. A. Humana Press, Totowa, NJ.
  • Thompson, H.J., and Sporn, M.B. (2002). Mammary cancer in rats. Tumor Models in Cancer Research, Teicher, B. A., Humana Press, Totowa, NJ.
  • Trainer, D.L., Kline, T., McCabe, F.L., Faucette, L.F., Feild, J., Chaikin, M., Anzano, M., Rieman, D., Hoffstein, S., Li, D.-J., Gennaro, D., Buscarino, C., Lynch, M., Poste, G., and Greig, R. (1988). Biological characterization and oncogene expression in human colorectal carcinoma cell lines. Int J Cancer 41, 287—96.[Web of Science][Medline] [Order article via Infotrieve]
  • Tuveson, D.A., and Jacks, T. (1999). Modeling human lung cancer in mice: similarities and shortcomings. Oncogene 18, 5318—24.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Tuveson, D.A., and Jacks, T. (2002). Technologically advanced cancermodeling in mice. Curr Opin Genet Dev 12, 105—10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Uckun, F.M., and Sensel, M.G. (2002). SCID mouse models of human leukemia and lymphoma as tools for new agent development. Tumor Models in Cancer Research, Teicher B. A., Humana Press, Totowa, NJ.
  • UKCCCR(1998). United kingdom coordinating committee on cancer research (UKCCCR) guidelines forthe welfare of animals in experimental neoplasia (second edition). Br J Cancer 77, 1—10.[Medline] [Order article via Infotrieve]
  • Vail, D.M., and MacEwen, E.G. (1997). Spontaneously occurring tumors in companion animals as models for drug development. Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and Approval, Teicher, B. A., Humana Press, Totowa, NJ.
  • van Dyke, T., and Jacks, T. (2002). Cancer modeling in the modern era: progress and challenges. Cell 108, 135—44.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Vanchieri, C. (2001). Move over, mouse: make way for the woodchucks, ferrets, and zebrafish. J Natl Cancer Inst 93, 418—9.[Free Full Text]
  • Vanderkerken, K., De Leenheer, E., Shipman, C., Asosingh, K., Willems, A., van Camp, B., and Croucher, P. (2003). Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. Cancer Res 63, 287—9.[Abstract/Free Full Text]
  • Wallace, J. (2000). Humane endpoints and cancer research. ILAR J 41, 87—93.[Medline] [Order article via Infotrieve]
  • Waters, D.J., and Bostwick, D.G. (1997). The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Res 17, 1467—70.[Web of Science][Medline] [Order article via Infotrieve]
  • Waters, D.J., Bostwick, D.G., and Murphy, G.P. (1998). Conference summary: first international workshop on animal models of prostate cancer. Prostate 36, 47—48.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Watson, A., Wu, X., and Bruchez, M. (2003). Lighting up cells with quantum dots. BioTechniques 34, 296—303.[Web of Science][Medline] [Order article via Infotrieve]
  • Wetterwald, A., van der Pluijm, G., Que, I., Sijmons, B., Buijs, J., Karperien, M., Lowik, C.W.G.M., Gautschi, E., Thalmann, G.N., and Cecchini, M.G. (2002). Optical imaging of cancer metastasis to bone marrow: a mouse model of minimal residual disease. Am J Pathol 160, 1143.[Abstract/Free Full Text]
  • Wheeler, D.L., Church, D.M., Federhen, S., Lash, A.E., Madden, T.L., Pontius, J.U., Schuler, G.D., Schriml, L.M., Sequeira, E., Tatusova, T.A., and Wagner, L. (2003). Database resources of the national center for biotechnology. Nucleic Acids Res 31, 28—33.[Abstract/Free Full Text]
  • Wichmann, M.W., Muller, C., Meyer, G., Adam, M., Angele, M.K., Eisenmenger S.J., and Schildberg, F.W. (2003). Different immune responses to abdominal surgery in men and women. Langenbeck's Arch Surg 387, 397—401.[Web of Science][Medline] [Order article via Infotrieve]
  • Wilmanns, C., Fan, D., O'Brian, C.A., Bucana, C.D., and Fidler, I.J. (1992). Orthotopic and ectopic organ environments differently influence the sensitivity of murine colon carcinoma cells to doxorubicin and 5-fluorouracil. Int J Cancer 52, 78—104.
  • Yang, H., Berger, F., Tran, C., Gambhir, S.S., and Sawyers, C.L. (2003). MicroPET imaging of prostate cancer in LNCAP-SR39TK-GFP mouse xenografts. Prostate 55, 39—47.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Yoneda, T., Aufdemorte, T.B., Nishimura, R., Nishikawa, N., Sakuda, M., Alsina, M.M., Chavez, J.B., and Mundy, G.R. (1991). Occurrence of hypercalcemia and leukocytosis with cachexia in a human squamous cell carcinoma of the maxilla in athymic nude mice: a novel experimental model of three concomitant paraneoplastic syndromes. J Clin Oncol 9, 468—77.[Abstract]
  • Zan, Y., Haag, J.D., Chen, K.S., Shepel, L.A., Wigington, D., Wang, Y.R., Hu, R., Lopez-Guajardo, C.C., Brose, H.L., Porter, K.I., Leonard, R.A., Hitt, A.A., Schommer, S.L., Elegbede, A.F., and Gould, M.N. (2003). Production of knockout rats using ENU mutagenesis and a yeast-based screening assay. Nat Biotechnol 21, 645—51.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
  • Zhang, Z., Yin, L., Zhang, Y., and Zhao, F. (2002). In situ transduction of cytosine deaminase gene followed by systemic use of 5-fluorocytosine inhibits tumor growth and metastasis in orthotopic prostate cancer mouse models. Chin Med J 115, 227—31.[Web of Science][Medline] [Order article via Infotrieve]

Toxicologic Pathology, Vol. 32, No. 1 suppl, 53-66 (2004)
DOI: 10.1080/01926230490424770
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Cancer Res.Home page
D. Boerboom, M. Paquet, M. Hsieh, J. Liu, S. P. Jamin, R. R. Behringer, J. Sirois, M. M. Taketo, and J. S. Richards
Misregulated Wnt/{beta}-Catenin Signaling Leads to Ovarian Granulosa Cell Tumor Development
Cancer Res., October 15, 2005; 65(20): 9206 - 9215.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Free Full Text (Free PDF) Free
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schuh, J. C.L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schuh, J. C.L.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?